YAKUODO HOLDINGS Co., Ltd. (TYO:7679)
1,432.00
-54.00 (-3.63%)
Nov 20, 2026, 3:30 PM JST
YAKUODO HOLDINGS Revenue
YAKUODO HOLDINGS had revenue of 45.72B JPY in the quarter ending August 31, 2026, with 5.32% growth. This brings the company's total for the last twelve months to 170.75B, up 8.08% year-over-year. In the fiscal year ending February 28, 2026, YAKUODO HOLDINGS had annual revenue of 163.81B with 7.80% growth. That makes YAKUODO HOLDINGS the 7,305th largest company in the world by revenue and 751st in Japan.
Revenue (ttm)
170.75B
Revenue Growth
+8.08%
P/S Ratio
0.16
Revenue / Employee
n/a
Employees
1,094
Market Cap
27.85B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Feb 28, 2026 | 163.81B | 11.85B | 7.80% |
| Feb 28, 2025 | 151.96B | 9.72B | 6.83% |
| Feb 29, 2024 | 142.24B | 13.45B | 10.44% |
| Feb 28, 2023 | 128.79B | 8.48B | 7.05% |
| Feb 28, 2022 | 120.31B | 9.78B | 8.84% |
| Feb 28, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 29, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 29, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Ain Holdings | 691.99B |
| Ohki Healthcare Holdings | 363.02B |
| Qol Holdings | 294.35B |
| Cawachi | 283.28B |
| Genky DrugStores | 224.10B |
| Medical System Network | 135.21B |
| Satudora Holdings | 100.33B |
| Pharmarise Holdings | 70.00B |
YAKUODO HOLDINGS News
- 1 year ago - Hitachi, ELITech Enter Manufacturing, Supply Agreement For Molecular Testing Of Infectious Disease - Nasdaq